OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity
Sushrut Kamerkar, Charan Leng, Olga Burenkova, et al.
Science Advances (2022) Vol. 8, Iss. 7
Open Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Macrophages in immunoregulation and therapeutics
Shanze Chen, Abdullah F. U. H. Saeed, Quan Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 727

Exosomes─Nature’s Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics
Rumiana Tenchov, Janet M. Sasso, Xinmei Wang, et al.
ACS Nano (2022) Vol. 16, Iss. 11, pp. 17802-17846
Open Access | Times Cited: 312

The role of extracellular vesicles in cancer
Raghu Kalluri, Kathleen M. McAndrews
Cell (2023) Vol. 186, Iss. 8, pp. 1610-1626
Closed Access | Times Cited: 284

Engineered exosomes from different sources for cancer-targeted therapy
Menghui Zhang, Shengyun Hu, Lin Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 196

Metabolism, metabolites, and macrophages in cancer
Mengyuan Li, Yuhan Yang, Liting Xiong, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 139

Tumor-Derived Extracellular Vesicles: Multifunctional Entities in the Tumor Microenvironment
James Clancy, Crislyn D’Souza‐Schorey
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 205-229
Open Access | Times Cited: 82

Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases
Guoping Li, Tianji Chen, James E. Dahlman, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 69

Extracellular Vesicles as Therapeutic Resources in the Clinical Environment
Jorge Sanz‐Ros, Cristina Mas‐Bargues, Nekane Romero-García, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2344-2344
Open Access | Times Cited: 53

UBE2M-mediated neddylation of TRIM21 regulates obesity-induced inflammation and metabolic disorders
Xinliang Lu, Xianghui Kong, Hao Wu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1390-1405.e8
Closed Access | Times Cited: 45

Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application
Qian Yang, Shisheng Li, Haibo Ou, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 39

Tumor immune escape: extracellular vesicles roles and therapeutics application
Mahdi Ahmadi, Reza Abbasi, Jafar Rezaie
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24

Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 24

The biology and function of extracellular vesicles in immune response and immunity
Raghu Kalluri
Immunity (2024) Vol. 57, Iss. 8, pp. 1752-1768
Closed Access | Times Cited: 22

Clinical landscape of macrophage-reprogramming cancer immunotherapies
Jenna H. Rannikko, Maija Hollmén
British Journal of Cancer (2024) Vol. 131, Iss. 4, pp. 627-640
Open Access | Times Cited: 16

Surface functionalization of exosomes for chondrocyte-targeted siRNA delivery and cartilage regeneration
Hao Zhang, Wenjing Yan, Jinhui Wang, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 493-505
Closed Access | Times Cited: 15

Gastric cancer-derived exosomal let-7 g-5p mediated by SERPINE1 promotes macrophage M2 polarization and gastric cancer progression
Zhenzhen Ye, Jianfeng Yi, Xiangyan Jiang, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 4

Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer
Xudong Zhu, Rongpu Liang, Tianyun Lan, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 9, pp. e004219-e004219
Open Access | Times Cited: 64

Nonresolving inflammation redux
Carl Nathan
Immunity (2022) Vol. 55, Iss. 4, pp. 592-605
Open Access | Times Cited: 62

STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma
Mingjing Jiang, Bo Li
Cells (2022) Vol. 11, Iss. 19, pp. 3131-3131
Open Access | Times Cited: 43

Targeting macrophages: a novel treatment strategy in solid tumors
Mengmeng Liu, Lina Liu, Yongping Song, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 41

Multiplexed strategies toward clinical translation of extracellular vesicles
Junying Song, Baoqiang Song, Lijun Yuan, et al.
Theranostics (2022) Vol. 12, Iss. 15, pp. 6740-6761
Open Access | Times Cited: 40

Extracellular vesicles as next generation immunotherapeutics
David W. Greening, Rong Xu, Anukreity Ale, et al.
Seminars in Cancer Biology (2023) Vol. 90, pp. 73-100
Closed Access | Times Cited: 39

Hybrid extracellular vesicles for drug delivery
Coline Ducrot, Stanislas Loiseau, Christophe Wong, et al.
Cancer Letters (2023) Vol. 558, pp. 216107-216107
Open Access | Times Cited: 38

Page 1 - Next Page

Scroll to top